BioLineRx Ltd. Share Premium
BioLineRx Ltd. (BLRX) had Share Premium of $327.58 million as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes
ifrs-full:SharePremium · last filed 2026-03-23
- 2025-12-31: Share Premium $327.58M.
- 2025-06-30: Share Premium $327.48M.
- 2024-12-31: Share Premium $353.69M.
- 2024-06-30: Share Premium $352.43M.
| Period end | Share Premium |
|---|---|
| 2025-12-31 | $327.58M 20-F · filed 2026-03-23 |
| 2025-06-30 | $327.48M 6-K · filed 2025-08-14 |
| 2024-12-31 | $353.69M 20-F · filed 2026-03-23 |
| 2024-06-30 | $352.43M 6-K · filed 2024-08-15 |
| 2023-12-31 | $355.48M 20-F · filed 2025-03-31 |
| 2023-06-30 | $339.05M 6-K · filed 2023-08-30 |
| 2022-12-31 | $338.98M 20-F · filed 2024-03-26 |
| 2022-06-30 | $339.67M 6-K · filed 2022-08-16 |
| 2021-12-31 | $339.35M 20-F · filed 2023-03-22 |
| 2021-06-30 | $335.89M 6-K · filed 2021-08-18 |
| 2020-12-31 | $279.24M 20-F · filed 2022-03-16 |
| 2020-06-30 | $271.11M 6-K · filed 2020-08-06 |
| 2019-12-31 | $265.94M 20-F · filed 2021-02-23 |
| 2019-06-30 | $261.52M 6-K · filed 2019-08-06 |
| 2018-12-31 | $250.19M 20-F · filed 2020-03-12 |
| 2018-06-30 | $243.88M 6-K · filed 2018-08-13 |
| 2017-12-31 | $240.68M 20-F · filed 2019-03-28 |
| 2016-12-31 | $199.57M 20-F · filed 2018-03-06 |